Filing Details
- Accession Number:
- 0001181431-11-061987
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-27 17:09:58
- Reporting Period:
- 2011-12-23
- Filing Date:
- 2011-12-27
- Accepted Time:
- 2011-12-27 17:09:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1192083 | B Susan Bayh | 4 Maguire Road Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-12-23 | 18,750 | $1.50 | 43,750 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-12-23 | 10,955 | $2.43 | 54,705 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-12-23 | 29,705 | $4.50 | 25,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2011-12-23 | 18,750 | $1.50 | 18,750 | $1.50 |
Common Stock | Non-qualified stock options (right to buy) | Disposition | 2011-12-23 | 10,955 | $2.43 | 10,955 | $2.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2002-06-05 | 2012-06-05 | No | 4 | M | Direct |
0 | 2003-05-13 | 2013-05-13 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2011.
- All shares were sold at $4.50/share.